Clinical Trial Update: Genetic Test To Identify Previously Undetectable Minimal Residual Disease in Cell Samples From Younger Patients With Acute Lymphoblastic Leukemia

View source ↗

Summary

A completed clinical trial update evaluating a genetic test to detect minimal residual disease in cell samples from children with acute lymphoblastic leukemia.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Acute Lymphoblastic Leukemia

Snippet

Sponsor: Children's Oncology Group | Conditions: Leukemia | Status: COMPLETED